Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
Open Access
- 21 February 2019
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 11 (2) , e4113
Abstract
To describe the characteristics of patients who present with brain metastases already at first diagnosis of cancer and to evaluate overall survival (OS) and long-term survival. Retrospective uni- and multivariate analyses in a group of 84 patients treated with different approaches. With respect to primary cancer type, the largest entities were adenocarcinoma non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) (34.5 and 21.4%, respectively). The most common diagnostic setting was symptomatic brain metastases (64 patients, 76.2%). Median OS was 7.2 months (one-year survival rate 31%). Four patients survived for at least three years, all had solitary metastases. The best survival was observed in the group managed with neurosurgical resection, median 17.7 months. Systemic treatment was also associated with better survival (median 9.7 vs. 2.8 months, p = 0.0001). Multivariate analysis revealed two prognostic baseline factors for OS, Karnofsky performance status (KPS) and number of brain metastases. Neurologic cause of death was uncommon (n = 14, 17%). Long-term survival was limited and observed exclusively in the setting of a solitary brain metastasis. In patients with good KPS and limited number of brain metastases, systemic treatment as well as effective local treatment, such as resection and/or radiotherapy with sufficiently high equivalent dose, is warranted.Keywords
This publication has 15 references indexed in Scilit:
- Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosisEuropean Journal of Cancer, 2017
- Survival of breast cancer patients with synchronous or metachronous central nervous system metastasesEuropean Journal of Cancer, 2015
- Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survivalLung Cancer, 2014
- Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ InvolvementClinical Oncology, 2014
- Incidence of brain metastasis at initial presentation of lung cancerNeuro-Oncology, 2014
- Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasisSurgery Today, 2014
- Best supportive care in patients with brain metastases and adverse prognostic factors: development of improved decision aidsSupportive Care in Cancer, 2013
- Presentation, patterns of care, and survival in patients with brain metastasesCancer, 2010
- Time for reappraisal of extracranial treatment options?Cancer, 2010
- Resource Utilization in Patients with Brain Metastases Managed with Best Supportive Care, Radiotherapy and/or Surgical Resection: A Markov AnalysisOncology, 2010